Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Teenagers with multiple sclerosis (MS) are less fit than healthy adolescents of the same age and sex, a new study has found. Researchers also found higher levels of fitness were associated with less...
A recent review has found that higher self-esteem, self-efficacy, resilience and social support are protective factors for quality of life in people with multiple sclerosis (MS). Conversely,...
The patterns of typing people display when using smartphones changes over time in people with multiple sclerosis (MS) but not in people without the condition, a new study has found. These changes...
People with multiple sclerosis (MS) might want to think twice about getting a tattoo, according to a new study published in the Journal of Applied Physiology. The reason is due to the tendency for...
The use of certain disease-modifying therapies (DMTs) in people with multiple sclerosis (MS) increases the risk of precancerous growths in those over 45, a new scientific analysis has found. The...
Researchers have discovered that a small protein found in beetroot can block the activity of prolyl oligopeptidase (POP), an enzyme that breaks down certain hormones and signalling molecules and...
A recent phase III trial has found that high-dose pharmaceutical-grade biotin (MD1003) does not improve disability or walking speed in people with progressive multiple sclerosis (MS). This outcome...
Researchers have characterised a new type of T-cell which produces a substance that contributes to the autoimmune response in multiple sclerosis (MS), paving the way for further studies and potential...
A new study has found that an anti-inflammatory drug administered nasally may reduce the progression of multiple sclerosis (MS) in mice. Researchers focused on molecules called inflammasomes which...
A drug which was rejected by the National Institute for Health & Care Excellence (NICE) in June has now been approved for use on the NHS in England and Wales as the first ever oral treatment for...

Pages